TL;DR
This study uncovers a novel molecular axis, MIR181A2HG/miR-5680/VCAN/CD44, that drives gastric cancer (GC) lymph node metastasis by promoting M2 macrophage polarization. This axis creates a positive feedback loop, suggesting MIR181A2HG as a promising therapeutic target for GC.
What Problem Does This Paper Address?
Gastric cancer (GC) is a significant global health concern, with a high mortality rate often attributed to tumor metastasis and recurrence. Lymphatic metastasis, in particular, is a major driver of poor prognosis. While lymphangiogenesis (the formation of new lymphatic vessels) is known to be crucial for this process, the precise molecular mechanisms, especially those involving tumor-associated macrophages (TAMs) and long non-coding RNAs (lncRNAs), remain largely elusive. This paper aims to elucidate the role of a specific lncRNA, MIR181A2HG, in GC lymph node metastasis and its underlying mechanisms.
Methods
The researchers employed a multi-faceted approach combining bioinformatics analysis, cell culture experiments, and in vivo models. Key techniques included:
- Bioinformatics Screening: Identifying MIR181A2HG as differentially expressed in GC using TCGA and GEO databases.
- Molecular Biology Techniques:
- qRT-PCR: Quantifying gene and miRNA expression.
- Immunofluorescence and Immunohistochemistry (IHC): Visualizing protein expression and cellular markers (e.g., CD163 for M2 macrophages, D2-40 and LYVE-1 for lymphatic vessels).
- Western Blot: Detecting protein levels.
- ELISA: Measuring protein concentrations in cell culture supernatants.
- Luciferase Reporter Assays: Verifying interactions between RNA molecules and promoter regions.
- RNA Pulldown and Co-Immunoprecipitation (Co-IP): Confirming direct binding between RNA and proteins.
- RNA Interference (siRNA): Knocking down gene expression to study functional consequences.
- Functional Assays:
- Tube Formation and Transwell Assays: Assessing lymphangiogenesis, migration, and invasion of lymphatic endothelial cells (HLECs).
- Macrophage Polarization Assays: Differentiating and analyzing macrophage phenotypes (M1 vs. M2).
- In Vivo Models:
- Popliteal Lymphatic Metastasis Model in Nude Mice: Evaluating the impact of MIR181A2HG on lymph node metastasis.
Datasets
- TCGA STAD (Stomach Adenocarcinoma) Database: Used for analyzing MIR181A2HG expression, its correlation with prognosis, and transcription factor binding.
- GEO Datasets (GSE109476 and GSE54129): Utilized for differential gene expression analysis of lncRNAs in GC.
- Online Databases:
- LncLocator: For predicting lncRNA subcellular localization.
- LncBase V2: For predicting downstream miRNAs of MIR181A2HG.
- TargetMiner, RNA22, DIANA-microT-CDS, TargetScan, MultiMIR: For predicting miRNA target genes.
- Genecard: For identifying macrophage-related genes.
- STRING, GeneMANIA, Hitpredict, Biogrid, Hint: For predicting protein-protein interactions.
- HumanTFDB, PAZAR, GTRD, TRANSFAC, HTFtarget, JASPAR: For predicting transcription factor binding sites.
Key Insights and Ideas
- MIR181A2HG as a Master Regulator: The study identifies MIR181A2HG as a key lncRNA that is significantly upregulated in GC and directly promotes lymph node metastasis.
- The ceRNA Axis: MIR181A2HG acts as a competing endogenous RNA (ceRNA) by sponging miR-5680, leading to the upregulation of its target gene, VCAN. This is a crucial mechanism for its downstream effects.
- VCAN's Dual Role: VCAN plays a critical role by interacting with CD44 on both macrophages (paracrine) and GC cells (autocrine), driving M2 macrophage polarization and activating the Hippo pathway, respectively.
- M2 Macrophages as Key Effectors: The study strongly implicates M2-polarized macrophages, induced by the MIR181A2HG axis, as central players in promoting lymphangiogenesis and subsequent metastasis via VEGF-C secretion.
- Positive Feedback Loop: A sophisticated positive feedback loop is established where VCAN, through CD44 and the Hippo pathway, upregulates SP1, which in turn drives MIR181A2HG transcription, perpetuating the metastatic process.
Key Results
- MIR181A2HG expression was significantly higher in GC tissues compared to normal tissues and correlated with advanced TNM stage, lymph node metastasis, and higher microlymphatic vessel density (MLVD).
- Knockdown of MIR181A2HG in GC cells significantly inhibited popliteal lymphatic metastasis in a mouse model, reducing tumor volume and weight of metastatic lymph nodes.
- MIR181A2HG promoted M2 macrophage polarization (indicated by increased CD163 and IL-10 expression) and suppressed M1 polarization (decreased iNOS, IL-6, and TNF-α).
- VCAN was identified as a direct target of miR-5680, and its expression was inversely correlated with miR-5680.
- VCAN significantly promoted M2 macrophage polarization and VEGF-C secretion, which in turn enhanced HLEC tube formation, migration, and invasion.
- SP1 was identified as a transcription factor that binds to the MIR181A2HG promoter, and its expression was positively correlated with MIR181A2HG. VCAN and CD44 signaling positively regulated SP1.
Limitations and Future Work
- Specific Molecular Mechanisms of VCAN-CD44 Interaction: While the interaction between VCAN and CD44 was confirmed, the precise downstream molecular mechanisms initiated by this binding on GC cells and macrophages require further detailed investigation.
- Therapeutic Strategy Design: The authors suggest MIR181A2HG-based targeted therapy as a novel strategy, but the specific design and preclinical validation of such therapies are not discussed.
- Clinical Translation: Further research is needed to translate these findings into clinical applications, including the development of diagnostic biomarkers and therapeutic interventions.
- Broader Impact of M2 Macrophages: While the study highlights M2 macrophage polarization, the broader implications of this polarization in the tumor microenvironment beyond lymphangiogenesis could be explored further.
Summary updated